oxybutynin has been researched along with Acute Coronary Syndrome in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The transdermal formulation of bisoprolol may be useful for the early introduction of β-blockers in patients admitted with cardiac symptoms associated with myocardial ischemia or heart failure." | 4.02 | An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms. ( Horiuchi, N; Kobayashi, T; Kobayashi, Y; Nakamura, S; Nakanishi, H; Naruhashi, K; Nozaki, A; Okugawa, H, 2021) |
| "Men with locally advanced or metastatic prostate cancer were randomly allocated (1:2 from August, 2007 then 1:1 from February, 2011) to either LHRHa according to local practice or tE2 patches (four 100 μg patches per 24 h, changed twice weekly, reducing to three patches twice weekly if castrate at 4 weeks [defined as testosterone ≤1·7 nmol/L])." | 3.01 | Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. ( Alhasso, A; Clarke, NW; Collins, GN; Deighan, JV; Dixit, S; Duong, T; Forcat, S; Gilbert, DC; Kockelbergh, R; Kynaston, H; Langley, RE; Laniado, ME; Macnair, A; Madaan, S; Manetta, C; Mangar, S; Marshall, J; McFarlane, J; Mckay, S; Muazzam, IA; Nankivell, M; Paez, E; Parmar, M; Pope, A; Robinson, A; Rosen, SD; Scrase, CD; Sundaram, SK; Weiss, M; Williams, ST; Worlding, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Nozaki, A | 1 |
| Kobayashi, T | 1 |
| Naruhashi, K | 1 |
| Okugawa, H | 1 |
| Horiuchi, N | 1 |
| Nakanishi, H | 1 |
| Kobayashi, Y | 1 |
| Nakamura, S | 1 |
| Langley, RE | 1 |
| Gilbert, DC | 1 |
| Duong, T | 1 |
| Clarke, NW | 1 |
| Nankivell, M | 1 |
| Rosen, SD | 1 |
| Mangar, S | 1 |
| Macnair, A | 1 |
| Sundaram, SK | 1 |
| Laniado, ME | 1 |
| Dixit, S | 1 |
| Madaan, S | 1 |
| Manetta, C | 1 |
| Pope, A | 1 |
| Scrase, CD | 1 |
| Mckay, S | 1 |
| Muazzam, IA | 1 |
| Collins, GN | 1 |
| Worlding, J | 1 |
| Williams, ST | 1 |
| Paez, E | 1 |
| Robinson, A | 1 |
| McFarlane, J | 1 |
| Deighan, JV | 1 |
| Marshall, J | 1 |
| Forcat, S | 1 |
| Weiss, M | 1 |
| Kockelbergh, R | 1 |
| Alhasso, A | 1 |
| Kynaston, H | 1 |
| Parmar, M | 1 |
| Kucuk, HO | 1 |
| Kucuk, U | 1 |
| Kolcu, Z | 1 |
| Balta, S | 1 |
| Demirkol, S | 1 |
1 trial available for oxybutynin and Acute Coronary Syndrome
| Article | Year |
|---|---|
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Topics: Acute Coronary Syndrome; Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Embolic Stro | 2021 |
2 other studies available for oxybutynin and Acute Coronary Syndrome
| Article | Year |
|---|---|
An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
Topics: Acute Coronary Syndrome; Acute Disease; Administration, Cutaneous; Adrenergic beta-1 Receptor Antago | 2021 |
Misuse of fentanyl transdermal patch mixed with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Analgesics, Opioid; Drug Overdose; Female; Fentanyl; Humans; Prescri | 2016 |